Clinical trial
Effect of Cyclical Administration of Interferon β-1b in Multiple Sclerosis - Comparison With Normal Dose.
NCT00270816 is registered in ClinicalTrials.gov with S. Andrea Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Cyclical Administration of Interferon β-1b in Multiple Sclerosis - Comparison With Normal Dose.
- Lead sponsor
- S. Andrea Hospital
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- November 30, 2005
- Completion date
- January 31, 2011
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.